Corewell Health is the new name for Beaumont.

One Unified System of Care: Find out how we’re creating a better experience and updating your MyChart.

The tumor registry (or oncology data services) at Beaumont, is an information system responsible for the collection, management, analysis and follow up of data on all patients with a diagnosis of malignancy or reportable benign disease. Once collected, these cases of cancer are reported to the State of Michigan's central registry as required by law. Information reported to the State includes demographic, medical, diagnostic, cancer information and treatment, and follow up. Patient identifying information is kept in the strictest of confidence and only aggregate data are analyzed and published without patient identifiers.

The registry provides support to the entire medical staff, the quality assessment efforts of the Cancer Committee, and to administrative planning for allocation of hospital resources. They promote quality assessment reviews and audits for evaluation of patient care, monitor trends in diagnostic and therapeutic techniques, provide lifetime follow up information on cancer patients, and provides incidence and survival data for comparison to local, regional and national trends.

A database for all patients diagnosed and/or treated at Beaumont with a malignancy or reportable benign tumor since January 1, 1973 is maintained with the reference date from American College of Surgeons (ACoS) of January 1, 1994 which means follow up is current on all patients from that year forward. Annual lifetime follow up of analytic cases is an American College of Surgeons requirement; at Beaumont, follow up is accomplished by monitoring inpatient and outpatient activities and by contacting physicians, other institutions or patients.

As an ACoS-approved cancer program with a computerized oncology database, Beaumont was also invited to participate in the National Cancer Data Base "Call for Data". As a participant, Beaumont receives "Patterns of Care", a general summary report of our hospital's data compared to the aggregate national data. The registry database has been used for a variety of purposes, including research studies, publications, grant applications, data to support Certificate of Need applications, and hospital planning.

The most frequently diagnosed sites (analytic cases only) at Beaumont in 2009 ( most current available data ) are:

Primary Site Beaumont State of MI % of MI cases
Breast 1,060 6,480 16.36%
Prostate 683 7,010 9.74%
Lung 521 8,190 6.36%
Colorectal 371 5,020 7.39%
Bladder 213 2,810 7.58%
Total cases 2,848 29,510 9.65%